Cryogenic enrichment of Plasmodium falciparum gametocytes from spiked whole blood.
Cryogenic
Enrichment
Gametocyte
Heterogenous sample
Plasmodium
Journal
Cryobiology
ISSN: 1090-2392
Titre abrégé: Cryobiology
Pays: Netherlands
ID NLM: 0006252
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
received:
17
08
2023
revised:
22
11
2023
accepted:
25
11
2023
pubmed:
2
12
2023
medline:
2
12
2023
entrez:
1
12
2023
Statut:
ppublish
Résumé
Each individual cell type typically requires a unique set of conditions for optimal cryopreservation outcome, which relates to its specific response to cryoprotective agent (CPA) toxicity, osmotic behavior and sensitivity to ice crystallization. Cryopreservation of heterogenous cell populations is therefore exceedingly difficult as it requires separate and often conflicting conditions for each cell type. Conversely, these contrasting conditions could be utilized to favor cryogenic preference of a single cell population within a heterogenous sample, leading to its enrichment by elimination of remaining cells. To establish proof-of-concept for this overall approach, a protocol was developed for the cryogenic enrichment of Plasmodium falciparum gametocytes from whole blood. To accomplish this goal, we evaluated the effects of CPAs and cooling conditions during cryopreservation of whole blood samples spiked with P. falciparum gametocytes. We identified that cooling to -80 °C at a rate of -1 °C/min in the presence of 11 % glycerol selectively favors recovery of gametocytes. This protocol eliminates 95.3 ± 1.7 % of total blood cells and recovers 43.2 ± 6.5 % of parasites, leading to a 19-fold enrichment as assessed by microscopic examination of blood smears. This protocol is tunable, where gametocyte enrichment 900-fold may be feasible, however there is an apparent tradeoff in overall parasite recovery. Although translation of this protocol for point-of-care testing for malaria presents many challenges, the overall approach of cryogenic purification may prove useful for alternative diagnostic applications.
Identifiants
pubmed: 38040049
pii: S0011-2240(23)00309-7
doi: 10.1016/j.cryobiol.2023.104810
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104810Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL157803
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI137558
Pays : United States
Organisme : NHLBI NIH HHS
ID : R00 HL143149
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI163950
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL143149
Pays : United States
Organisme : NIH HHS
ID : R24 OD034189
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.